0000899243-18-009111.txt : 20180402
0000899243-18-009111.hdr.sgml : 20180402
20180402200750
ACCESSION NUMBER: 0000899243-18-009111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180329
FILED AS OF DATE: 20180402
DATE AS OF CHANGE: 20180402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwartz Jonathan David
CENTRAL INDEX KEY: 0001726398
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 18731000
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-29
0
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001726398
Schwartz Jonathan David
C/O ROCKET PHARMACEUTICALS, INC.
430 EAST 29TH STREET, SUITE 1040
NEW YORK
NY
10016
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
18.75
2018-03-29
4
A
0
60000
0.00
A
2028-03-29
Common Stock
60000
60000
D
This option represents a right to purchase a total of 60,000 shares of the Issuer's Common Stock, 20,000 of which will become fully vested and exercisable on March 29, 2019, with the remaining 40,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
/s/ Alice Lee, as attorney-in-fact for Jonathan Schwartz
2018-04-02